Loading...
XSHE
002391
Market cap527mUSD
Dec 05, Last price  
5.97CNY
1D
1.53%
1Q
-3.08%
Jan 2017
-48.77%
IPO
-58.90%
Name

Jiangsu Changqing Agrochemical Co Ltd

Chart & Performance

D1W1MN
XSHE:002391 chart
P/E
P/S
1.06
EPS
Div Yield, %
3.35%
Shrs. gr., 5y
-0.65%
Rev. gr., 5y
0.86%
Revenues
3.52b
-2.49%
303,573,575414,784,321630,905,946676,314,453755,434,9251,001,151,8051,270,852,5471,568,668,8581,808,980,7611,820,809,2891,832,821,3592,245,305,8843,000,795,0693,377,169,6243,008,259,2563,764,717,6824,243,592,7633,614,477,6833,524,360,122
Net income
-120m
L
20,253,45245,817,98095,172,022101,127,897106,645,741113,444,563159,515,759192,546,092234,166,645237,561,333162,645,909227,898,176319,432,523370,835,681194,959,420248,534,907262,351,11673,113,919-119,953,643
CFO
318m
P
24,315,94436,538,437163,744,46725,120,95804,945,195164,152,783205,124,973225,446,946182,576,373194,177,456515,069,727608,574,446374,438,900347,133,347428,704,958845,087,235-77,891,755317,958,732
Dividend
Jun 21, 20240.2 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Jiangsu Changqing Agrochemical Co., Ltd. manufactures and sells pesticides in China, Europe, the United States, and Southeast Asia. Its technical materials comprise fomesafen, acifluorfen, fluoroglycofen-ethyl, lactofen, clomazone, imazethapyr, bromoxynil octanoate, nicosulfuron, benazolin-ethyl, clethodim, tricyclazole, fenoxanil, imidacloprid, acetamiprid, diafenthiuron, mesotrione, s-metolachlor, clodinafop-propargyl, dicamba, indoxacarb, fipronil, thiamethoxam, indoxacarb technical concentrate, clethodim mother liquor, cyhalofop-butyl active compound, prosulfuron active compound, pretilachlor active compound, azoxystrobin active compound, glyphosate active compound, chlorpyrifos active compound, triazophos, dimethazone, and triasulfuron active compound materials; and formulations include insecticides, bactericides, and herbicides. The company is based in Yangzhou, China.
IPO date
Apr 16, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT